DBT and Escitalopram in Borderline Personality Disorder
| Status: | Recruiting |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 60 |
| Updated: | 4/2/2016 |
| Contact: | Emily Hart |
| Email: | mpgroup@mssm.edu |
| Phone: | 212-241-0441 |
Effects of Dialectical Behavioral Therapy and Escitalopram on Impulsive Aggression, Affective Instability and Cognitive Processing in Borderline Personality Disorder
Subjects will receive six months of DBT, consisting of one 90-minute group and one 60-minute
individual session per week as well as telephone availability of the individual therapist.
Half the subjects will concurrently receive escitalopram while half will receive placebo, in
a randomized double-blind design.
individual session per week as well as telephone availability of the individual therapist.
Half the subjects will concurrently receive escitalopram while half will receive placebo, in
a randomized double-blind design.
Inclusion Criteria: Is a male or female between 18 and 60 who meets criteria for
Borderline Personality Disorder and has been off psychotropic medications for at least 2
weeks (6 weeks for fluoxetine).
Exclusion Criteria: Meets criteria for Schizophrenia, Bipolar Disorder, Mental
Retardation, current or recent Substance Dependence or a current Major Depressive Episode.
Subjects also should not currently be in individual psychotherapy. (Case management and
work therapy programs are allowed.)
We found this trial at
1
site
Click here to add this to my saved trials
